Cargando…
Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors?
PURPOSE: To investigate whether elevated glucose metabolism in neurofibroma, determined by [F18]-FDG-PET, is correlated with cell density in MRI, as expressed through the apparent diffusion coefficient. MATERIALS AND METHODS: Patients diagnosed with neurofibromatosis type 1 and peripheral nerve shea...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716584/ https://www.ncbi.nlm.nih.gov/pubmed/29206885 http://dx.doi.org/10.1371/journal.pone.0189093 |
_version_ | 1783283979740250112 |
---|---|
author | Berzaczy, Dominik Mayerhoefer, Marius E. Azizi, Amedeo A. Haug, Alexander R. Senn, Daniela Beitzke, Dietrich Weber, Michael Traub-Weidinger, Tatjana |
author_facet | Berzaczy, Dominik Mayerhoefer, Marius E. Azizi, Amedeo A. Haug, Alexander R. Senn, Daniela Beitzke, Dietrich Weber, Michael Traub-Weidinger, Tatjana |
author_sort | Berzaczy, Dominik |
collection | PubMed |
description | PURPOSE: To investigate whether elevated glucose metabolism in neurofibroma, determined by [F18]-FDG-PET, is correlated with cell density in MRI, as expressed through the apparent diffusion coefficient. MATERIALS AND METHODS: Patients diagnosed with neurofibromatosis type 1 and peripheral nerve sheath tumors (PNST) were enrolled in this prospective, IRB-approved study. After a single [F18]-FDG injection, patients consecutively underwent [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI on the same day. Maximum and mean standardized uptake values (SUVmax, SUVmean) on [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI were compared, and correlated with minimum and mean apparent diffusion coefficients (ADCmean, ADCmin). RESULTS: A total of 12 (6 male/6 female, mean age was 16.2 ± 5.2 years) patients were prospectively included and analyzed on a per-lesion (n = 39) basis. The SUVmean of examined PNST showed a moderate negative correlation with the ADCmean (r = -.441) and ADCmin (r = -.477), which proved to be statistically significant (p = .005 and p = .002). The SUVmax of the respective lesions, however, showed a weaker negative correlation for ADCmean (r: -.311) and ADCmin (r: -.300) and did not reach statistical significance (p = .054 and p = .057). Lesion-based correlation between [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT showed a moderate correlation for SUVmax (r = .353; p = .027) and a strong one for SUVmean (r = .879; p = .001)). Patient-based liver uptake (SUVmax and mean) of [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT were strongly positively correlated (r = .827; p < .001 and r = .721; p < .001) but differed significantly (p < .001). CONCLUSIONS: We found a statistically significant, negative correlation between glucose metabolism and cell density in PNST. Thus, ADCmean and ADCmin could possibly add complimentary information to the SUVmax and SUVmean and may serve as a potential determinant of malignant transformation of PNST. |
format | Online Article Text |
id | pubmed-5716584 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Public Library of Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-57165842017-12-15 Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors? Berzaczy, Dominik Mayerhoefer, Marius E. Azizi, Amedeo A. Haug, Alexander R. Senn, Daniela Beitzke, Dietrich Weber, Michael Traub-Weidinger, Tatjana PLoS One Research Article PURPOSE: To investigate whether elevated glucose metabolism in neurofibroma, determined by [F18]-FDG-PET, is correlated with cell density in MRI, as expressed through the apparent diffusion coefficient. MATERIALS AND METHODS: Patients diagnosed with neurofibromatosis type 1 and peripheral nerve sheath tumors (PNST) were enrolled in this prospective, IRB-approved study. After a single [F18]-FDG injection, patients consecutively underwent [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI on the same day. Maximum and mean standardized uptake values (SUVmax, SUVmean) on [F18]-FDG-PET/CT and [F18]-FDG-PET/MRI were compared, and correlated with minimum and mean apparent diffusion coefficients (ADCmean, ADCmin). RESULTS: A total of 12 (6 male/6 female, mean age was 16.2 ± 5.2 years) patients were prospectively included and analyzed on a per-lesion (n = 39) basis. The SUVmean of examined PNST showed a moderate negative correlation with the ADCmean (r = -.441) and ADCmin (r = -.477), which proved to be statistically significant (p = .005 and p = .002). The SUVmax of the respective lesions, however, showed a weaker negative correlation for ADCmean (r: -.311) and ADCmin (r: -.300) and did not reach statistical significance (p = .054 and p = .057). Lesion-based correlation between [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT showed a moderate correlation for SUVmax (r = .353; p = .027) and a strong one for SUVmean (r = .879; p = .001)). Patient-based liver uptake (SUVmax and mean) of [F18]-FDG-PET/MRI and [F18]-FDG-PET/CT were strongly positively correlated (r = .827; p < .001 and r = .721; p < .001) but differed significantly (p < .001). CONCLUSIONS: We found a statistically significant, negative correlation between glucose metabolism and cell density in PNST. Thus, ADCmean and ADCmin could possibly add complimentary information to the SUVmax and SUVmean and may serve as a potential determinant of malignant transformation of PNST. Public Library of Science 2017-12-05 /pmc/articles/PMC5716584/ /pubmed/29206885 http://dx.doi.org/10.1371/journal.pone.0189093 Text en © 2017 Berzaczy et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. |
spellingShingle | Research Article Berzaczy, Dominik Mayerhoefer, Marius E. Azizi, Amedeo A. Haug, Alexander R. Senn, Daniela Beitzke, Dietrich Weber, Michael Traub-Weidinger, Tatjana Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors? |
title | Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors? |
title_full | Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors? |
title_fullStr | Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors? |
title_full_unstemmed | Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors? |
title_short | Does elevated glucose metabolism correlate with higher cell density in Neurofibromatosis type 1 associated peripheral nerve sheath tumors? |
title_sort | does elevated glucose metabolism correlate with higher cell density in neurofibromatosis type 1 associated peripheral nerve sheath tumors? |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5716584/ https://www.ncbi.nlm.nih.gov/pubmed/29206885 http://dx.doi.org/10.1371/journal.pone.0189093 |
work_keys_str_mv | AT berzaczydominik doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors AT mayerhoefermariuse doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors AT aziziamedeoa doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors AT haugalexanderr doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors AT senndaniela doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors AT beitzkedietrich doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors AT webermichael doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors AT traubweidingertatjana doeselevatedglucosemetabolismcorrelatewithhighercelldensityinneurofibromatosistype1associatedperipheralnervesheathtumors |